JUVÉDERM VOLBELLA XC approved in U.S. for increasing lip fullness
FDA approves injectable gel to plump lips and reduce lines around the lips. Read More »
Grünenthal GmbH receives exclusive rights to Zurampic from AstraZeneca
Licensing agreement gives Grünenthal GmbH exclusive rights in Europe and Latin America. Read More »
Alcon and Cheryl Ladd partner to raise awareness of cataracts
"Know Your Cataract EYE-Q" campaign launched to educate consumers about cataracts and their treatment. Read More »
Vascepa eligible for FDA new chemical entity marketing exclusivity
Prescription omega-3 fatty acid diet aid protected by statute until 2020. Read More »
Aetna announces application with State of Maryland to provide Medicaid services
Aetna has applied to become a Medicaid managed care organization under Aetna Better Health of Maryland. Read More »
Incyte and Moffitt join forces against blood cancers
The research support and collaboration is focused on developing therapies for specific blood cancers. Read More »
Supreme Court may review Washington pharmacy case
A federal appeals court ruled that pharmacists cannot refuse to fill prescriptions that may violate their religious beliefs. Read More »
Phase I bladder cancer trial data presented at ASCO annual meeting
Astellas and Seattle Genetics presented ASB-15ME and ASG-22ME clinical trial data today. Read More »
Bosworth partners with Allegan in launch of new acne treatment gel
Actress, model and producer shares her personal experience with adult acne. Read More »
FDA approves BYVALSON to treat hypertension
Combination of beta blocker and angiotensin II receptor blocker approved to treat high blood pressure. Read More »
EC grants orphan medicinal product designation to AGTC gene therapy product
New hope for XLRP patients; gene therapy may slow or cure vision loss. Read More »
Additional data on IMBRUVICA presented at ASCO annual meeting
Positive trial results in treating CLL/SLL; favorable PFS and OS shown in longer-term follow up data. Read More »
Science survey results announced by Amgen and CTEq
Survey reveals that students learn best with hands-on experiments and field trips. Read More »
Amgen announces positive PFS results in Phase III ASPIRE trial
Early relapsing patients treated with Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone (KRd) showed median PFS of 24.1 months. Read More »
FDA issues draft guidance on COPD drug development
The U.S. Food and Drug Administration (FDA) added information on using the St. George’s Respiratory Questionnaire (SGRQ) in its newest version of draft guidance in drug development for Chronic Obstructive Pulmonary Disease (COPD). Read More »
Amarin to present data on Vascepa at American Diabetes Association sessions
Analysis of the Phase III ANCHOR trial to be displayed in a poster presentation. Read More »
Efient 20 mg tablet now available from Daichi Sankyo
The antiplatelet agent, Efient, is now available in 20 milligram form, Daiichi Sankyo recently announced. Read More »
HS sufferers find support from AbbVie
(HS) education campaign designed to support those suffering from the skin disease. Read More »
Business Council of New York State opposes attempt to amend law on prescription drug purchase
The Business Council of New York State is not supporting legislation that seeks to amend the pharmaceutical law governing the purchase of prescription drugs. Read More »
APhA announces 2016 board election results
The American Pharmacists Association (APhA) announced the election results for the organization’s board of trustees. Read More »
Alerts Sign-up